Equity Investees (Tables)

12 Months Ended

Dec. 31, 2019

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Consolidated Financial Statements Related To Equity Investees

The following table presents information included in our Consolidated Financial Statements related to our equity investees.

 

	Year Ended December 31,
	2019			2018			2017
Genesis’ share of operating earnings	$	71,975		$	59,255		$	66,814
Amortization of differences attributable to Genesis' carrying value of equity investments	(15,491		)	(15,629		)	(15,768		)
Net equity in earnings	$	56,484		$	43,626		$	51,046
Distributions received	$	77,331		$	71,714		$	82,898

Schedule of Balance Sheet Information For Equity Investees

The following tables present the combined balance sheet information for the last two years and income statement data for the last three years for our equity investees (on a 100% basis):

	December 31,
	2019		2018
BALANCE SHEET DATA:
Assets
Current assets	$	44,129	$	34,005
Fixed assets, net	321,752		346,864
Other assets	16,739		15,469
Total assets	$	382,620	$	396,338
Liabilities and equity
Current liabilities	$	20,081	$	18,897
Other liabilities	252,331		250,742
Equity	110,208		126,699
Total liabilities and equity	$	382,620	$	396,338

Schedule of Operations For Equity Investees

	Year Ended December 31,
	2019		2018		2017
INCOME STATEMENT DATA:
Revenues	$	209,674	$	180,056	$	191,078
Operating Income	$	155,920	$	129,160	$	139,604
Net Income	$	139,436	$	115,669	$	134,479